CoChat

RETRACTED ARTICLE: Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function

Open access
Zhang, Yingmei, Babcock, Sara A, Hu, Nan, Maris, Jacalyn R, Wang, Haichang, Ren, Jun · 2012 · BMC Medicine
Cited by 130

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: Mitochondrial aldehyde dehydrogenase (ALDH2) displays some promise in the protection against cardiovascular diseases although its role in diabetes has not been elucidated. Methods: This study was designed to evaluate the impact of ALDH2 on streptozotocin-induced diabetic cardiomyopathy. Friendly virus B(FVB) and ALDH2 transgenic mice were treated with streptozotocin (intraperitoneal injection of 200 mg/kg) to induce diabetes. Results: Echocardiographic evaluation revealed reduced fractional shortening, increased end-systolic and -diastolic diameter, and decreased wall thickness in streptozotocin-treated FVB mice. Streptozotocin led to a reduced respiratory exchange ratio; myocardial apoptosis and mitochondrial damage; cardiomyocyte contractile and intracellular Ca 2+ defects, including depressed peak shortening and maximal velocity of shortening and relengthening; prolonged duration of shortening and relengthening; and dampened intracellular Ca 2+ rise and clearance. Western blot analysis revealed disrupted phosphorylation of Akt, glycogen synthase kinase-3β and Foxo3a (but not mammalian target of rapamycin), elevated PTEN phosphorylation and downregulated expression of mitochondrial proteins, peroxisome proliferator-activated receptor γ coactivator 1α and UCP-2. Intriguingly, ALDH2 attenuated or ablated streptozotocin-induced echocardiographic, mitochondrial, apoptotic and myocardial contractile and intracellular Ca 2+ anomalies as well as changes in the phosphorylation of Akt, glycogen synthase kinase-3β, Foxo3a and phosphatase and tensin homologue on chromosome ten, despite persistent hyperglycemia and a low respiratory exchange ratio. In vitro data revealed that the ALDH2 activator Alda-1 and glycogen synthase kinase-3β inhibition protected against high glucose-induced mitochondrial and mechanical anomalies, the effect of which was cancelled by mitochondrial uncoupling. Conclusions: In summary, our data revealed that ALDH2 acted against diabetes-induced cardiac contractile and intracellular Ca 2+ dysregulation, possibly through regulation of apoptosis, glycogen synthase kinase-3β activation and mitochondrial function independent of the global metabolic profile.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1741-7015-10-40This paper is marked retracted.

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 34

  1. Budas GR, Disatnik MH, Mochly-Rosen D: Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target?. Trends Cardiovasc Med. 2009, 19: 158-164. 10.1016/j.tcm.2009.09.003. · DOI · Paper page
  2. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D: Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science. 2008, 321: 1493-1495. 10.1126/science.1158554. · DOI · Paper page
  3. Ma H, Guo R, Yu L, Zhang Y, Ren J: Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur Heart J. 2011, 32: 1025-1038. 10.1093/eurheartj/ehq253. · DOI · Paper page
  4. Zhang Y, Ren J: ALDH2 in alcoholic heart diseases: Molecular mechanism and clinical implications. Pharmacol Ther. 2011, 132: 86-95. 10.1016/j.pharmthera.2011.05.008. · DOI · Paper page
  5. Doser TA, Turdi S, Thomas DP, Epstein PN, Li SY, Ren J: Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation. 2009, 119: 1941-1949. 10.1161/CIRCULATIONAHA.108.823799. · DOI · Paper page
  6. Koda K, Salazar-Rodriguez M, Corti F, Chan NY, Estephan R, Silver RB, Mochly-Rosen D, Levi R: Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation. 2010, 122: 771-781. 10.1161/CIRCULATIONAHA.110.952481. · DOI
  7. Ma H, Li J, Gao F, Ren J: Aldehyde dehydrogenase 2 ameliorates acute cardiac toxicity of ethanol: role of protein phosphatase and forkhead transcription factor. J Am Coll Cardiol. 2009, 54: 2187-2196. 10.1016/j.jacc.2009.04.100. · DOI
  8. Matsuoka K: Genetic and environmental interaction in Japanese type 2 diabetics. Diabetes research and clinical practice. 2000, 50 (Suppl 2): S17-22. · doi:10.1016/s0168-8227(00)00174-1
  9. Peng GS, Yin SJ: Effect of the allelic variants of aldehyde dehydrogenase ALDH2*2 and alcohol dehydrogenase ADH1B*2 on blood acetaldehyde concentrations. Hum Genomics. 2009, 3: 121-127. · DOI · Paper page
  10. Xu F, Chen Y, Lv R, Zhang H, Tian H, Bian Y, Feng J, Sun Y, Li R, Wang R, Zhang Y: ALDH2 genetic polymorphism and the risk of type II diabetes mellitus in CAD patients. Hypertens Res. 2010, 33: 49-55. 10.1038/hr.2009.178. · DOI
  11. Ikegami H, Noso S, Babaya N, Hiromine Y, Kawabata Y: Genetic basis of type 1 diabetes: similarities and differences between East and West. Rev Diabet Stud. 2008, 5: 64-72. 10.1900/RDS.2008.5.64. · DOI
  12. Wang J, Wang H, Hao P, Xue L, Wei S, Zhang Y, Chen Y: Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats. Mol Med. 2011, 17: 172-179. · DOI
  13. Dakeishi M, Murata K, Sasaki M, Tamura A, Iwata T: Association of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 genotypes with fasting plasma glucose levels in Japanese male and female workers. Alcohol Alcohol. 2008, 43: 143-147. · DOI
  14. Ma H, Yu L, Byra EA, Hu N, Kitagawa K, Nakayama KI, Kawamoto T, Ren J: Aldehyde dehydrogenase 2 knockout accentuates ethanol-induced cardiac depression: role of protein phosphatases. J Mol Cell Cardiol. 2010, 49: 322-329. 10.1016/j.yjmcc.2010.03.017. · DOI
  15. Oudit GY, Penninger JM: Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res. 2009, 82: 250-260. · DOI · Paper page
  16. Li Q, Li J, Ren J: UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK. Am J Physiol Endocrinol Metab. 2009, 297: E965-973. 10.1152/ajpendo.00323.2009. · DOI
  17. Li SY, Li Q, Shen JJ, Dong F, Sigmon VK, Liu Y, Ren J: Attenuation of acetaldehyde-induced cell injury by overexpression of aldehyde dehydrogenase-2 (ALDH2) transgene in human cardiac myocytes: role of MAP kinase signaling. J Mol Cell Cardiol. 2006, 40: 283-294. 10.1016/j.yjmcc.2005.11.006. · DOI
  18. Park YJ, Kim SC, Kim J, Anakk S, Lee JM, Tseng HT, Yechoor V, Park J, Choi JS, Jang HC, Lee KU, Novak CM, Moore DD, Lee YK: Dissociation of diabetes and obesity in mice lacking orphan nuclear receptor small heterodimer partner. J Lipid Res. 2011, 52: 2234-2244. 10.1194/jlr.M016048. · DOI
  19. Li SY, Ren J: Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress. J Mol Cell Cardiol. 2008, 44: 992-1001. 10.1016/j.yjmcc.2008.02.276. · DOI
  20. Davidoff AJ, Ren J: Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes. Am J Physiol. 1997, 272: H159-167.
  21. Ge W, Guo R, Ren J: AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol. Free Radic Biol Med. 2011, 51: 1736-1748. 10.1016/j.freeradbiomed.2011.08.002. · DOI
  22. Zhang Y, Xia Z, La Cour KH, Ren J: Activation of Akt rescues endoplasmic reticulum stress-impaired murine cardiac contractile function via glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeation pore opening. Antioxid Redox Signal. 2011, 15: 2407-2424. 10.1089/ars.2010.3751. · DOI
  23. Zhang B, Turdi S, Li Q, Lopez FL, Eason AR, Anversa P, Ren J: Cardiac overexpression of insulin-like growth factor 1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction but not hypertrophy: roles of Akt, mTOR, GSK3beta, and PTEN. Free Radic Biol Med. 2010, 49: 1238-1253. 10.1016/j.freeradbiomed.2010.07.020. · DOI
  24. Ma H, Li SY, Xu P, Babcock SA, Dolence EK, Brownlee M, Li J, Ren J: Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med. 2009, 13: 1751-1764. 10.1111/j.1582-4934.2008.00547.x. · DOI · Paper page
  25. Ren J, Duan J, Thomas DP, Yang X, Sreejayan N, Sowers JR, Leri A, Kajstura J, Gao F, Anversa P: IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. Am J Physiol Regul Integr Comp Physiol. 2008, 294: R793-802. 10.1152/ajpregu.00713.2007. · DOI · Paper page
  26. Wold LE, Ceylan-Isik AF, Fang CX, Yang X, Li SY, Sreejayan N, Privratsky JR, Ren J: Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme. Free Radic Biol Med. 2006, 40: 1419-1429. 10.1016/j.freeradbiomed.2005.12.009. · DOI
  27. Ren J, Pulakat L, Whaley-Connell A, Sowers JR: Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med. 2010, 88: 993-1001. 10.1007/s00109-010-0663-9. · DOI · Paper page
  28. Dong F, Li Q, Sreejayan N, Nunn JM, Ren J: Metallothionein prevents high-fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated receptor gamma coactivator 1alpha and mitochondrial biogenesis. Diabetes. 2007, 56: 2201-2212. 10.2337/db06-1596. · DOI · Paper page
  29. Bugger H, Chen D, Riehle C, Soto J, Theobald HA, Hu XX, Ganesan B, Weimer BC, Abel ED: Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes. 2009, 58: 1986-1997. 10.2337/db09-0259. · DOI · Paper page
  30. Sano M: Cardioprotection by hormetic responses to aldehyde. Circ J. 2010, 74: 1787-1793. 10.1253/circj.CJ-10-0716. · DOI
  31. Turdi S, Li Q, Lopez FL, Ren J: Catalase alleviates cardiomyocyte dysfunction in diabetes: role of Akt, Forkhead transcriptional factor and silent information regulator 2. Life Sci. 2007, 81: 895-905. 10.1016/j.lfs.2007.07.029. · DOI
  32. Miura T, Tanno M: Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury. Cardiovasc Drugs Ther. 2010, 24: 255-263. 10.1007/s10557-010-6234-z. · DOI
  33. Juhaszova M, Zorov DB, Yaniv Y, Nuss HB, Wang S, Sollott SJ: Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res. 2009, 104: 1240-1252. 10.1161/CIRCRESAHA.109.197996. · DOI · Paper page
  34. Zhang Y, Yuan M, Bradley KM, Dong F, Anversa P, Ren J: Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function. Hypertension. 2012, 59: 680-693. 10.1161/HYPERTENSIONAHA.111.181867. · DOI

Cited by

See all 130

Metadata

Authors
Zhang, Y., Babcock, S. A., Hu, N., Maris, J. R., Wang, H., & Ren, J.
Venue
BMC Medicine
Published
2012-04-23
Volume
10
Issue
1
Pages
40-40
ISSN
1741-7015 (ISSN-L)
OpenAlex
W2081551661
Cited by
130
References
4
FWCI
5.82
Type
journal article
Language
en
Status
Retracted
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RETRACTED ARTICLE: Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function. https://app.cochat.ai/papers/10.1186/1741-7015-10-40
The paper
Zhang, Y., Babcock, S. A., Hu, N., Maris, J. R., Wang, H., & Ren, J. (2012). RETRACTED ARTICLE: Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function. BMC Medicine. https://doi.org/10.1186/1741-7015-10-40

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.